Fund code: 244

  • NAV
    $33.45 $0.12 / 0.37%
    31-May-2023
  • Inception 25-Sep-2001
  • Benchmark MSCI AC World Health Care Index
  • Aggregate assets
    (all series)
    $65.4M
    30-Apr-2023
  • MER 2.25%
    30-Nov-2022
  • Distributions Annually
  • Morningstar category Sector Equity
  • Also available through: Trust US$ and Trust CDN$
  • Get Fund Facts

End investment

Annualized return

Choose a chart type (percentage or dollar)
Choose a predefined chart period
to:

Start NAV

$10.0000

End NAV

$10.4031
Choose a predefined chart period
to:

Calendar returns (%) 31-May-2023

YTD 2023 2022 2021 2020 2019 2018 2017 2016
Fund -1.27 -7.74 19.22 9.18 18.30 13.85 10.93 -15.20

Standard period returns (%) 31-May-2023

1 mo 3 mo 6 mo 1 yr 3 yr 5 yr 10 yr Inception
Fund -3.39 1.89 -2.83 4.68 3.93 8.61 11.20 5.72

Why invest in this fund?

  • Offers exposure to dynamic growth opportunities across the global health care sector.
  • Leverages Fidelity’s expertise in managing industry-specific funds.
  • See important fund suitability notice*

Risk measures (%) 30-Apr-2023

Fund
Annualized standard deviation 12.03
Beta 1.00
0.89

Risk classification

  1. Low
  2. Low to medium
  3. Medium
  4. Medium to high
  5. High

This fund has a medium volatility rating

Allocation

Asset mix (%)

30-Apr-2023

Country mix (%)

30-Apr-2023

Sector mix (%)

30-Apr-2023
12 months ago Last month Current month
Pharma Products 24.7 26.8 27.4
Life Sciences Tools & Services 27.3 24.7 23.2
Health Care Equipment & Supplies 19.4 22.0 22.2
Health Care Providers & Services 16.8 16.3 16.8
Biotech. 8.2 6.4 6.1

Top ten holdings

  1. UnitedHealth Group
  2. Thermo Fisher Scientific
  3. ROCHE HLDGS AG (GENUSSCHEINE)
  4. Stryker
  5. AbbVie
  6. Danaher
  7. Elevance Health
  8. Boston Scientific
  9. Sonova Holding
  10. Novo-Nordisk, Cl. B
Total number of holdings 45
Top ten holdings aggregate 52.9%
  1. UnitedHealth Group
  2. Johnson & Johnson
  3. Thermo Fisher Scientific
  4. ROCHE HLDGS AG (GENUSSCHEINE)
  5. AstraZeneca
  6. AbbVie
  7. Elevance Health
  8. Danaher
  9. Stryker
  10. Bristol-Myers Squibb
Total number of holdings 44
Top ten holdings aggregate 52.5%
  1. UnitedHealth Group
  2. ROCHE HLDGS AG (GENUSSCHEINE)
  3. Thermo Fisher Scientific
  4. Johnson & Johnson
  5. Danaher
  6. Elevance Health
  7. Bristol-Myers Squibb
  8. AstraZeneca
  9. AbbVie
  10. Stryker
Total number of holdings 47
Top ten holdings aggregate 53.4%
  1. UnitedHealth Group
  2. Thermo Fisher Scientific
  3. AstraZeneca
  4. Bristol-Myers Squibb
  5. ICON plc
  6. AbbVie
  7. ROCHE HLDGS AG (GENUSSCHEINE)
  8. Danaher
  9. IQVIA
  10. Elevance Health
Total number of holdings 50
Top ten holdings aggregate 53.2%
View all